Global Cardiovascular Health
Rheumatic heart disease, LMIC delivery, fixed-dose combinations and equity.
Global cardiovascular health programming addresses the disproportionate CV disease burden in low- and middle-income countries, where 80 percent of CV deaths now occur. The track features the WHF rheumatic heart disease (RHD) elimination roadmap, Dig-RHD AI-echo screening programs, secondary penicillin prophylaxis registries, and the operational realities of valve surgery in resource-limited settings. Sessions also cover fixed-dose combination polypills (HOPE-3, TIPS-3), task-shifting cardiovascular care to community health workers, hypertension control strategies (May Measurement Month), Chagas in non-endemic regions, and equity in clinical trial enrollment.
- Rheumatic heart disease: WHF roadmap and Dig-RHD AI screening
- Secondary penicillin prophylaxis and valve surgery in LMICs
- Fixed-dose combination polypills (HOPE-3, TIPS-3)
- Task-shifting CV care to community health workers
- Hypertension control programs (May Measurement Month)
- Chagas in non-endemic regions and migrant populations
- Equity in clinical trial enrollment and guideline applicability